tiprankstipranks
Trending News
More News >
Merus Announces Promising Phase 2 Trial Results
PremiumCompany AnnouncementsMerus Announces Promising Phase 2 Trial Results
1M ago
Biohaven provides oncology program update
Premium
The Fly
Biohaven provides oncology program update
1M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
1M ago
Promising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and Safety
PremiumRatingsPromising Potential of Merus’s Petosemtamab: A Buy Rating Backed by Impressive Efficacy and Safety
1M ago
Merus’s Peto+Pembro Shows Promising Potential in HNSCC with High Survival Rates and Increased Price Target
Premium
Ratings
Merus’s Peto+Pembro Shows Promising Potential in HNSCC with High Survival Rates and Increased Price Target
1M ago
Merus’s Promising Oncology Advancements Justify Buy Rating Amidst Strong Clinical Results
Premium
Ratings
Merus’s Promising Oncology Advancements Justify Buy Rating Amidst Strong Clinical Results
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100